Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Trading Update

11 Dec 2017 07:00

RNS Number : 8906Y
K3 Capital Group PLC
11 December 2017
 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries, the "Group")

Trading update

 

K3 Capital Group plc, a leading business and company sales specialist in the UK, today announces a trading update ahead of its interim results for the six-month period ended 30 November 2017 (the "Interim Results"), which will be announced on 16 January 2018.

 

The Interim Results will demonstrate a continuation of the Group's strong performance across all three divisions with significant uplifts from the comparable prior year period ("H117").

 

The Board is pleased to report that the Group will record revenue of approximately £7.5m, an increase of 34 per cent. compared to H117 and EBITDA of approximately £3.3m, an increase of 27 per cent. compared to H117. Both revenue and EBITDA figures are comfortably in line with market expectations for the full year ending 31 May 2018.

 

The Board remains committed to paying a progressive dividend to shareholders and accordingly will declare a dividend payment in the Interim Results in January.

 

John Rigby, Chief Executive Officer, commented:

 

"I am delighted to report on what has been a strong six months for K3, comfortably in line with market expectations. The Group's three brands continue to gain recognition and market share within their fields, and we are pursuing our stated strategy of increasing the average deal size across the Company.

 

"The Group is encouraged by the significant pipeline and we remain optimistic that we will continue to deliver growth against our core KPIs over the coming six months and beyond."

 

For further information please contact:

K3 Capital Group plc

Tel: c/o Newgate 020 7680 6550

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

finnCap Ltd (Nominated Adviser and Sole Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Emily Watts, Anthony Adams (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

Newgate Communications Ltd (Financial PR)

Tel: 020 7680 6550

Alistair Kellie, Zoë Pocock, James Ash

k3capital@newgatecomms.com

 

About K3 Capital

K3 Capital Group plc is a leading business sales and brokerage firm headquartered in Bolton with operations throughout the UK. It acts for vendors of businesses from c. £50,000 to c. £50 million through its three trading subsidiaries Knightsbridge, KBS Corporate, and KBS Corporate Finance.

 

K3 Capital operates a disruptive business model with a direct marketing approach to client acquisition, using incentivised and experienced salespeople rather than advisory teams, while its highly visible online presence and proprietary online business valuation portal generates further leads. This innovative model, combined with a continuing strategy towards targeting higher value clients, are key drivers for growth and profitability.

 

The Group also offers all clients fully contingent and inclusive legal fees through its partner relationship with Gateley.

 

K3 Capital Group trades on the London Stock Exchange (AIM: K3C.L), having listed on 11 April 2017.

Please visit www.k3capitalgroupplc.com for more information.

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLIFILILID
Date   Source Headline
7th Sep 20207:00 amRNSInvestor Presentation
7th Aug 20202:36 pmRNSHolding(s) in Company
7th Aug 202011:26 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSAcquisition, Directorate Changes & Results Notice
21st Jul 20204:32 pmRNSHolding(s) in Company
21st Jul 20202:51 pmRNSHolding(s) in Company
20th Jul 20203:51 pmRNSHolding(s) in Company
20th Jul 20202:35 pmRNSHolding(s) in Company
17th Jul 202011:30 amRNSResult of General Meeting
2nd Jul 20205:40 pmRNSHolding(s) in Company
2nd Jul 20205:37 pmRNSHolding(s) in Company
1st Jul 20202:37 pmRNSHolding(s) in Company
1st Jul 202011:59 amRNSHolding(s) in Company
30th Jun 20202:00 pmRNSPosting of Circular and Notice of General Meeting
29th Jun 20202:05 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 20201:25 pmRNSResult of Fundraising
29th Jun 20207:01 amRNSPrimaryBid.com Offers
29th Jun 20207:00 amRNSProposed Fundraising to Raise up to £30.5 million
7th Apr 20204:42 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSTrading Update
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
28th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20203:00 pmRNSDirector/PDMR Shareholding
5th Feb 20202:30 pmRNSDirector/PDMR Shareholding
4th Feb 20207:00 amRNSHalf-year Report
16th Dec 20197:00 amRNSTrading Update
20th Nov 20196:05 pmRNSHolding(s) in Company
18th Oct 20191:30 pmRNSResult of AGM
17th Sep 20191:43 pmRNSFinal Dividend Timetable
17th Sep 20197:00 amRNSNotice of AGM
17th Sep 20197:00 amRNSFinal Results
21st Aug 201910:25 amRNSHolding(s) in Company
17th Jun 201912:00 pmRNSCorrection: Director/PDMR Shareholding
14th Jun 20192:40 pmRNSDirector/PDMR Shareholding
6th Jun 20192:09 pmRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSTrading Update and Notice of Results
16th May 20194:30 pmRNSHolding(s) in Company
8th Apr 201911:41 amRNSHolding(s) in Company
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSHalf-year Report
12th Dec 20187:00 amRNSLeading Advisor in Mid-Market M&A Adviser Rankings
11th Dec 20187:00 amRNSTrading Update
6th Dec 20184:52 pmRNSHolding(s) in Company
11th Oct 201811:05 amRNSSecond Price Monitoring Extn
11th Oct 201811:00 amRNSPrice Monitoring Extension
26th Sep 20185:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.